Article | August 21, 2023

Lowering The Lipid Barrier: Enabling Any Scientist To Be A Genomic Medicine Developer

LNP Formulations Feature
Figure 1. Pre-optimized formulations and off-the-shelf lipid nanoparticle kits

Nanomedicine is a promising treatment strategy to target a range of diseases with limited side effects and complications. Although RNA (ribonucleic acid) molecules are fragile and can degrade quickly, new non-viral gene delivery approaches, such as nanoparticles, have the potential to deliver a range of RNA-based therapeutics and vaccines effectively. Learn how you can fast-track RNA-LNP development and streamline screening with off-the-shelf ionizable lipid mixes as well as utilize these validation strategies using ready-made formulations to generate reproducible and scalable LNPs for lead candidates.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online